Overview and Analysis of Rare Disease Drugs Approved for Market in China, the United States, the European Union, and Japan in 2023

Objective To summarize and analyze what the listing in market of orphan drugs in China, the United States, the European Union, and Japan in 2023, and to provide empirical reference to Chinese pharmaceutical enterprises, pharmaceutical management, and new drug research and development departments....

Full description

Bibliographic Details

Published in:	罕见病研究
Main Authors:	WANG Shaohong, LIU Xin, LIU Qingyang, TANG Yan, ZHANG Bo
Format:	Article
Language:	Chinese
Published:	Editorial Office of Journal of Rare Diseases 2024-04-01
Subjects:	rare diseases orphan drugs marketed approved drug
Online Access:	https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2024.02.008